Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice

Virus Research

Volumn 90, Issue 1-2, 2002, Pages 317-326

  Osorio, Yanira ^a   Wechsler, Steven L ^a   Nesburn, Anthony B ^a   Ghiasi, Homayon ^a,b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corneal scarring; Herpetic blepharitis; Interleukin

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; PROTEIN SUBUNIT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENE DISRUPTION; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; VIRUS TITRATION;

ANIMALS; BLEPHARITIS; CORNEA; CYTOKINES; FEMALE; HERPESVIRUS 1, HUMAN; INTERLEUKIN-12; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; RABBITS; SEVERITY OF ILLNESS INDEX;

HUMAN HERPESVIRUS 1;

EID: 0036891629     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00249-6     Document Type: Article

References (58)

1. Biron C.A. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr. Opin. Immunol. 6:1994;530-538.
2. Brunda M.J. Interleukin-12. J. Leukocyte Biol. 55:1994;280-288.
3. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospisil M., Young H.A., Wolf S.F., Young D., Clark S.C., Trinchieri G. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:1991;869-879.
4. Cooper A.M., Kipnis A., Turner J., Magram J., Ferrante J., Orme I.M. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168:2002;1322-1327.
5. Daheshia M., Deshpande S., Chun S., Kuklin N.A., Rouse B.T. Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice. Virology. 257:1999;168-176.
6. D'Andrea A., Rengaraju M., Valiante N.M., Chehimi J., Kubin M., Aste M., Chan S.H., Kobayashi M., Young D., Nickbarg E., et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1992;1387-1398.
7. Dawson C.R., Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv. Ophthalmol. 21:1976;121-135.
8. Decken K., Kohler G., Palmer-Lehmann K., Wunderlin A., Mattner F., Magram J., Gately M.K., Alber G. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immunol. 66:1998;4994-5000.
9. Deshpande S.P., Zheng M., Daheshia M., Rouse B.T. Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice. J. Virol. 74:2000;3517-3524.
10. Doymaz M.Z., Rouse B.T. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest. Ophthalmol. Vis. Sci. 33:1992;2165-2173.
11. Easty D.L., Shimeld C., Claoue C.M., Menage M. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr. Eye Res. 6:1987;69-74.
12. Gazzinelli R.T., Hieny S., Wynn T.A., Wolf S., Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA. 90:1993;6115-6119.
13. Gearing D.P., Cosman D. Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell. 66:1991;9-10.
14. Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., Wechsler S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J. Virol. 68:1994;2118-2126.
15. Ghiasi H., Bahri S., Nesburn A.B., Wechsler S.L. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest. Ophthalmol. Vis. Sci. 36:1995;1352-1360.
16. Ghiasi H., Wechsler S.L., Kaiwar R., Nesburn A.B., Hofman F.M. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J. Virol. 69:1995;334-340.
17. Ghiasi H., Wechsler S.L., Cai S., Nesburn A.B., Hofman F.M. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology. 95:1998;352-359.
18. Ghiasi H., Cai S., Slanina S.M., Perng G.C., Nesburn A.B., Wechsler S.L. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease. J. Infect. Dis. 179:1999;1086-1093.
19. Ghiasi H., Hofman F.M., Cai S., Perng G.C., Nesburn A.B., Wechsler S.L. Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice. Vaccine. 17:1999;2576-2582.
20. Ghiasi H., Hofman F.M., Wallner K., Cai S., Perng G., Nesburn A.B., Wechsler S.L. Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines. Vaccine. 19:2000;1266-1273.
21. Gillessen S., Carvajal D., Ling P., Podlaski F.J., Stremlo D.L., Familletti P.C., Gubler U., Presky D.H., Stern A.S., Gately M.K. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:1995;200-206.
22. Godfrey D.I., Kennedy J., Gately M.K., Hakimi J., Hubbard B.R., Zlotnik A. IL-12 influences intrathymic T cell development. J. Immunol. 152:1994;2729-2735.
23. Gubler U., Chua A.O., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., Nabavi N., Wolitzky A.G., Quinn P.M., Familletti P.C., et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA. 88:1991;4143-4147.
24. Guler M.L., Gorham J.D., Hsieh C.S., Mackey A.J., Steen R.G., Dietrich W.F., Murphy K.M. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science. 271:1996;984-987. (see comments).
25. Heiligenhaus A., Foster C.S. Histological and immunopathological analysis of T-cells mediating murine HSV-1 keratitis. Graefes. Arch. Clin. Exp. Ophthalmol. 232:1994;628-634.
26. Hendricks R.L., Tumpey T.M. Concurrent regeneration of T lymphocytes and susceptibility to HSV-1 corneal stromal disease. Curr. Eye Res. 10:1991;47-53.
27. Hendricks R.L., Epstein R.J., Tumpey T. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Invest. Ophthalmol. Vis. Sci. 30:1989;105-115.
28. Hendricks R.L., Janowicz M., Tumpey T.M. Critical role of corneal langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J. Immunol. 148:1992;2522-2529.
29. Hochrein H., O'Keeffe M., Luft T., Vandenabeele S., Grumont R.J., Maraskovsky E., Shortman K. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:2000;823-833.
30. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., Murphy K.M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549. (see comments).
31. Jayaraman S., Heiligenhaus A., Rodriguez A., Soukiasian S., Dorf M.E., Foster C.S. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J. Immunol. 151:1993;5777-5789.
32. Kanangat S., Thomas J., Gangappa S., Babu J.S., Rouse B.T. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression: implications in immunopathogenesis and protection. J. Immunol. 156:1996;1110-1116.
33. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., Su C., Pan Y.C., Hakimi J. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:1995;116-127.
34. Locksley R.M. Interleukin 12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA. 90:1993;5879-5880.
35. Macatonia S.E., Hosken N.A., Litton M., Vieira P., Hsieh C.S., Culpepper J.A., Wysocka M., Trinchieri G., Murphy K.M., O'Garra A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154:1995;5071-5079.
36. Magram J., Connaughton S.E., Warrier R.R., Carvajal D.M., Wu C.Y., Ferrante J., Stewart C., Sarmiento U., Faherty D.A., Gately M.K. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity. 4:1996;471-481.
37. Magram J., Sfarra J., Connaughton S., Faherty D., Warrier R., Carvajal D., Wu C.Y., Stewart C., Sarmiento U., Gately M.K. IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann. NY Acad. Sci. 795:1996;60-70.
38. Manickan E., Kanangat S., Rouse R.J., Yu Z., Rouse B.T. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukocyte Biol. 61:1997;125-132.
39. Mattner F., Magram J., Ferrante J., Launois P., Di Padova K., Behin R., Gately M.K., Louis J.A., Alber G. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1996;1553-1559.
40. McIntyre K.W., Shuster D.J., Gillooly K.M., Warrier R.R., Connaughton S.E., Hall L.B., Arp L.H., Gately M.K., Magram J. Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol. 26:1996;2933-2938.
41. Merberg D.M., Wolf S.F., Clark S.C. Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol. Today. 13:1992;77-78.
42. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348-2357.
43. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:2000;715-725.
44. Opremcak E.M., Rice B.A., Wells P.A., Foster C.S. Histology and immunohistology of Igh-1-restricted herpes simplex keratitis in BALB/c congenic mice. Invest. Ophthalmol. Vis. Sci. 31:1990;305-312.
45. Orange J.S., Biron C.A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense: studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1996;1138-1142.
46. Oxenius A., Karrer U., Zinkernagel R.M., Hengartner H. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162:(2):1999;965-973.
47. Pepose J.S. External ocular herpes virus infections in immunodeficiency. Curr. Eye Res. 10:1991;87-95.
48. Piccotti J.R., Li K., Chan S.Y., Ferrante J., Magram J., Eichwald E.J., Bishop D.K. Alloantigen-reactive Th1 development in IL-12-deficient mice. J. Immunol. 160:1998;1132-1138.
49. Sarmiento M. Intrinsic resistance to viral infection: mouse macrophage restriction of herpes simplex virus replication. J. Immunol. 141:1988;2740-2748.
50. Scharton-Kersten T., Afonso L.C., Wysocka M., Trinchieri G., Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:1995;5320-5330.
51. Schijns V.E., Haagmans B.L., Wierda C.M., Kruithof B., Heijnen I.A., Alber G., Horzinek M.C. Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 160:1998;3958-3964.
52. Schwarz T. Interleukin-12 and its role in cutaneous sensitization. Res. Immunol. 146:1995;494-499.
53. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 260:(5107):1993;496-497.
54. Sieburth D., Jabs E.W., Warrington J.A., Li X., Lasota J., LaForgia S., Kelleher K., Huebner K., Wasmuth J.J., Wolf S.F. Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics. 14:1992;59-62.
55. Stern A.S., Podlaski F.J., Hulmes J.D., Pan Y.C., Quinn P.M., Wolitzky A.G., Familletti P.C., Stremlo D.L., Truitt T., Chizzonite R., et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 87:1990;6808-6812.
56. Tumpey T.M., Chen S.H., Oakes J.E., Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:1996;898-904.
57. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R.M., et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:1991;3074-3081.
58. Wynn T.A., Eltoum I., Oswald I.P., Cheever A.W., Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1994;1551-1561.